XML 41 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Description of Business, Basis of Presentation, Going Concern and Restatement of Financial Statement (Tables)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Schedule of Error Corrections and Prior Period Adjustments
The following table illustrates the effects of the error corrections on the balance sheet:
As of June 30, 2023Previously ReportedAdjustmentsRestated
ASSETS
Total current assets$3,664 $— $3,664 
Property and equipment, net1,796 — 1,796 
Right-of-use asset6,893 — 6,893 
Investment in convertible notes receivable— 2,000 2,000 
Other noncurrent assets5,202 (2,000)3,202 
Total assets$17,555 $— $17,555 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Total liabilities7,850 — 7,850 
Contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.0001 par value per share; 10,000,000 shares authorized, no shares issued and outstanding, June 30, 2023 and December 31, 2022
— — — 
Common stock, $0.0001 par value per share; 200,000,000 shares authorized, 8,648,307 issued and outstanding, June 30, 2023; 4,965,901 issued and outstanding, December 31, 2022
— 
Additional paid-in capital192,524 — 192,524 
Accumulated deficit(182,820)— (182,820)
Total stockholders’ equity9,705 — 9,705 
Total liabilities and stockholders’ equity$17,555 $— $17,555 
The following table illustrates the effects of the error corrections to operating expenses:
For the three months ended June 30, 2023Previously ReportedAdjustmentsRestated
Research and development expense$921 $(921)$— 
General and administrative expense4,721 921 5,642 
Total operating expenses$5,642 $— $5,642 
For the six months ended June 30, 2023Previously ReportedAdjustmentsRestated
Research and development expense$2,902 $(1,479)$1,423 
General and administrative expense7,279 1,479 8,758 
Total operating expenses$10,181 $— $10,181